{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T02:29:06Z","timestamp":1715653746245},"reference-count":20,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Pressure"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.1080\/080370500300000914","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T16:00:13Z","timestamp":1027699213000},"page":"335-339","source":"Crossref","is-referenced-by-count":4,"title":["The Placebo Effect and White Coat Effect in Isolated Systolic Hypertension and Systo-diastolic hypertension"],"prefix":"10.1080","volume":"9","author":[{"family":"Dirk C. Felmeden, Gregory Y. H. Lip","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"key":"CIT0001","first-page":"11","volume":"90","author":"Wilson PW","year":"1991","journal-title":"Castelli WP. Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham Offspring Study. Am J Med"},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/archinte.1992.00400130082009","volume":"152","author":"Neaton JD","year":"1992","journal-title":"Arch Intern Med"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/121.5.754"},{"key":"CIT0005","first-page":"393","volume":"8","author":"Straessen J","year":"1990","journal-title":"Isolated systolic hyperten-sion in the elderly. J Hypertens"},{"key":"CIT0006","first-page":"3451","volume":"260","author":"Wilking SVB","year":"1988","journal-title":"Determinants of isolated systolic hypertension. JAMA"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/01.CIR.61.6.1179","volume":"61","author":"Kannel WB","year":"1980","journal-title":"Perspectives on systolic hypertension. The Framingham Study. Circulation"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/01.STR.22.3.312","volume":"22","author":"Wolf PA","year":"1991","journal-title":"Stroke"},{"key":"CIT0009","first-page":"3255","volume":"265","author":"SHEP Cooperative Research","year":"1991","journal-title":"Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA"},{"key":"CIT0011","first-page":"1823","volume":"16","author":"Liu L","year":"1998","journal-title":"Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic hypertension in China (Sys-China) Collaboration Group. J Hypertens"},{"key":"CIT0012","first-page":"173","volume":"42","author":"Pannerale G","year":"1994","journal-title":"Effetto placebo e pressione arteriosa. [Placebo effect and arterial blood pressure.] Minerva Cardioangiol"},{"key":"CIT0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00004872-199715010-00010","volume":"15","author":"Kuppers HE","year":"1997","journal-title":"J Hypertens"},{"key":"CIT0016","first-page":"175","volume":"13","author":"Staessen JA","year":"1995","journal-title":"Ambulatory pressure, 'white-coat' pressor responses andcardiovascular risk in placebo-group patients of the MRC Mild Hypertension trial. J Hypertens"},{"key":"CIT0017","first-page":"203","volume":"17","author":"Silagy CA","year":"1990","journal-title":"isolated systolic hypertension-does it exist on 24 hour ambulatory blood pressure monitoring (ABPM)? Clin Exp Pharmacol Physiol"},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/00004872-199210000-00001","volume":"10","author":"Thijs L","year":"1992","journal-title":"J Hypertens"},{"key":"CIT0019","first-page":"23","volume":"16","author":"Parati G","year":"1998","journal-title":"Limitations of the difference between clinic and daytime blood pressure as a surrogate measure of the 'white-coat' effect. Syst-Eur investigators. J Hypertens"},{"key":"CIT0020","first-page":"567","volume":"7","author":"Paran E","year":"1993","journal-title":"J Hum Hypertens"},{"key":"CIT0023","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0165-6147(81)90359-X","volume":"2","author":"Fleisch JH","year":"1981","journal-title":"Trends Pharmacol Sci"},{"key":"CIT0024","doi-asserted-by":"crossref","first-page":"M21\u2013M24","DOI":"10.1093\/geronj\/43.1.M21","volume":"43","author":"Simpson DM","year":"1988","journal-title":"J Gerontol"},{"key":"CIT0025","first-page":"103","volume":"3","author":"Hossmann V","year":"1981","journal-title":"Influence of hospitalisation and placebo therapy on blood pressure and sympathetic function in essential hypertension. Hypertens"},{"key":"CIT0026","first-page":"1183","volume":"61","author":"Kannel WB","year":"1980","journal-title":"Gordon T. Labile hypertension: a faulty concept? The Framingham study. Circulation"}],"container-title":["Blood Pressure"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/080370500300000914","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,28]],"date-time":"2017-11-28T09:41:57Z","timestamp":1511862117000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/080370500300000914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2009,7,8]]},"published-print":{"date-parts":[[2000,1]]}},"alternative-id":["10.1080\/080370500300000914"],"URL":"https:\/\/doi.org\/10.1080\/080370500300000914","relation":{},"ISSN":["0803-7051","1651-1999"],"issn-type":[{"value":"0803-7051","type":"print"},{"value":"1651-1999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}